rs1464992494

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PVS1_Moderate

The NM_000218.3(KCNQ1):​c.1906dupG​(p.Ala636GlyfsTer16) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000421 in 1,426,522 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A636A) has been classified as Likely benign. The gene KCNQ1 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000042 ( 0 hom. )

Consequence

KCNQ1
NM_000218.3 frameshift

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 0.149

Publications

1 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1-AS1 (HGNC:42790): (KCNQ1 antisense RNA 1)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000218.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0611 CDS is truncated, and there are 1 pathogenic variants in the truncated region.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000218.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ1
NM_000218.3
MANE Select
c.1906dupGp.Ala636GlyfsTer16
frameshift
Exon 16 of 16NP_000209.2
KCNQ1
NM_001406836.1
c.1810dupGp.Ala604GlyfsTer16
frameshift
Exon 15 of 15NP_001393765.1
KCNQ1
NM_001406837.1
c.1636dupGp.Ala546GlyfsTer16
frameshift
Exon 17 of 17NP_001393766.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ1
ENST00000155840.12
TSL:1 MANE Select
c.1906dupGp.Ala636GlyfsTer16
frameshift
Exon 16 of 16ENSP00000155840.2P51787-1
KCNQ1
ENST00000335475.6
TSL:1
c.1525dupGp.Ala509GlyfsTer16
frameshift
Exon 16 of 16ENSP00000334497.5P51787-2
KCNQ1
ENST00000910997.1
c.1903dupGp.Ala635GlyfsTer16
frameshift
Exon 16 of 16ENSP00000581056.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000421
AC:
6
AN:
1426522
Hom.:
0
Cov.:
31
AF XY:
0.00000425
AC XY:
3
AN XY:
706442
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32698
American (AMR)
AF:
0.00
AC:
0
AN:
40554
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25436
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37622
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81658
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49348
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5720
European-Non Finnish (NFE)
AF:
0.00000548
AC:
6
AN:
1094512
Other (OTH)
AF:
0.00
AC:
0
AN:
58974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Beckwith-Wiedemann syndrome;C1837014:Atrial fibrillation, familial, 3;C1865019:Short QT syndrome type 2;C4551509:Jervell and Lange-Nielsen syndrome 1;C4551647:Long QT syndrome 1 (1)
-
1
-
Cardiac arrhythmia (1)
-
1
-
Long QT syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.15
Mutation Taster
=42/158
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1464992494;
hg19: chr11-2869104;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.